PTC Therapeutics, Inc. Deferred Revenue
PTC Therapeutics, Inc. (PTCT) had Deferred Revenue of $0 as of 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-05-09
- 2018-03-31: Deferred Revenue, Current $0.00.
- 2017-12-31: Deferred Revenue, Current $3.94M.
- 2017-09-30: Deferred Revenue, Current $6.12M.
- 2017-06-30: Deferred Revenue, Current $2.60M.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $3.94M 10-Q · filed 2018-05-09 | |
| 2017-09-30 | $6.12M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $2.60M 10-Q · filed 2017-08-09 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-06 | |
| 2016-09-30 | $910.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $726.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $396.00K 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $139.00K 10-K · filed 2017-03-16 | |
| 2015-03-31 | $373.00K 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $3.35M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $769.00K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $242.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $492.00K 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $878.00K 10-K · filed 2015-03-02 | $877.43K 10-K · filed 2014-03-06 |
| 2013-09-30 | $3.63M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $6.98M 10-Q · filed 2013-08-13 | |
| 2012-12-31 | $16.69M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |